Supernus Pharmaceuticals | SUPN - Net Income



Supernus Pharmaceuticals reported $22.5M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Abbott USD 1.78B 454M Jun/2025
ANI Pharmaceuticals USD 8.14M 7.54M Jun/2025
Aurora Cannabis CAD -15210000 46.88M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Canopy Growth CAD -41530000 80.37M Jun/2025
Corcept Therapeutics USD 35.15M 14.6M Jun/2025
Eisai JPY 14.47B 13.52B Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Novo Nordisk 26.5B 2.53B Jun/2025
Pacira USD -4847000 9.66M Jun/2025
Perrigo USD -8400000 2M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Supernus Pharmaceuticals USD 22.5M 34.33M Jun/2025
United Therapeutics USD 309.5M 12.7M Jun/2025
Xeris Pharmaceuticals USD -1930000 52.91M Jun/2025